Alex is an Investment Partner of Syncona Investment Management Ltd.
He is a Director on the Boards of SwanBio Therapeutics and Anaveon. Previously, he was a member of the Healthcare Investment Banking team at Jefferies, where he worked on a range of financings and mergers and acquisitions across the biotechnology, pharmaceutical and healthcare sectors. Alex has a PhD in Immunology from the University of Cambridge.
Syncona portfolio companies
- SwanBio Therapeutics (Board member)
- Anaveon (Board member)